Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AAIPharma Services | Contract Pharma
Breaking News, Promotions & Moves

AAIPharma Services

Tim Martin has been appointed executive vice president of sales and marketing at AAIPharma Services, and Rob Goshert has been named vice president of corporate accounts.

Tim Martin has been appointed executive vice president of sales and marketing at AAIPharma Services, and Rob Goshert has been named vice president of corporate accounts. Both will join the company’s senior management team.

“Tim and Rob bring a wealth of pharmaceutical and biotechnology experience,” said Patrick Walsh, chief executive officer of AAIPharma Services. “Tim’s background in marketing and leading high-growth business teams combined with Rob’s focus on business development and customer service will add immense value to our efforts to expand our services and offer greater value to our customers in the future.”

Mr. Martin has more than 25 years of sales and marketing leadership experience in both product and service offerings in the pharmaceutical and biotechnology sectors. Most recently, he was president and chief executive officer of Express, a specialty provider of logistics services to hospitals, labs and other healthcare businesses. He also served in executive roles with several healthcare companies including as senior vice president and general manager of Cardinal Health’s Specialty Pharmaceutical Services division.

Mr. Goshert brings 30 years of leadership experience in business development, sales and marketing, business operations and corporate accounts. His experience covers proprietary pharmaceuticals, critical care generics, parenteral contract manufacturing, bioassay diagnostics, and pharmaceutical development services in previous executive roles at LyphoMed, Fujisawa USA and Gensia Sicor.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters